Local anaesthesia in term- and preterm infants

Background Local anaesthesia is known to be a safe and effective method for postoperative pain management in adults and children. This convenient method is however rarely used in term and preterm infants, despite its obvious benefits. This is due to lack of research and experience in the area. The free fraction of local anaesthetics is responsible for both toxicity and efficacy. Alpha-1-acid-glycoprotein (AAGP) has a high affinity for amide local anaesthetics, thus plasma levels of AAGP determine the free fraction of LA. This is why this glycoprotein is important when determining dosages of LA infusions. There are very few studies concerning AAGP in newborns and none in extremely preterm infants. Aims • To assess the safety and efficacy of local anaesthesia administered by wound catheter after major surgery in termand preterm infants. • To investigate levels of alpha-1-acid-glycoprotein in new-borns after delivery, and their correlation to age and mode of delivery. Methods The studies were performed at departments of Neonatology and Paediatric Anaesthesia and Intensive care at Karolinska University Hospital. All patients were term and preterm newborn infants. In the first two studies blood was obtained postoperatively after major surgery from patients with wound catheters for determination of Levobupivacaine (LB) concentrations after intermittent (StudyI) or continuous (Study II) infusion with LB: The first study used a sampling protocol of six samples over a 24 hour period and the second study used four samples in 72 hours. Pain was assessed using validated pain scales and morphine consumption was registered. In Study III levels of AAGP was determined in blood sampled from umbilical arteries direct after delivery. Results/Conclusions Studies I and II: The studied infusion regimens with LB administered by wound catheters was associated with plasma levels of LB well below toxicity. We also noted good wound healing, low pain scores and reduced need for opioids compared to our normal clinical experience. Study III: This study suggest a significant correlation between increasing gestational age and increasing levels of AAGP in plasma. AAGP levels in plasma seem to correspond with increasing maturity of the new-born infant. Gender and birth weight did not seem to influence AAGP concentrations in plasma. Infants born vaginally had significantly higher levels of AAGP compared to those born with planned caesarean section. • Local anaesthesia by wound catheter administration in termand preterm new-born infants is a safe method to use. • Gestational age and mode of delivery should be factors when determining dosage of local anaesthetics. Abstract Background Local anaesthesia is known to be a safe and effective method for postoperative pain management in adults and children. This convenient method is however rarely used in term and preterm infants, despite its obvious benefits. This is due to lack of research and experience in the area. The free fraction of local anaesthetics is responsible for both toxicity and efficacy. Alpha-1-acid-glycoprotein (AAGP) has a high affinity for amide local anaesthetics, thus plasma levels of AAGP determine the free fraction of LA. This is why this glycoprotein is important when determining dosages of LA infusions. There are very few studies concerning AAGP in newborns and none in extremely preterm infants. Aims • To assess the safety and efficacy of local anaesthesia administered by wound catheter after major surgery in termand preterm infants. • To investigate levels of alpha-1-acid-glycoprotein in new-borns after delivery, and their correlation to age and mode of delivery. Methods The studies were performed at departments of Neonatology and Paediatric Anaesthesia and Intensive care at Karolinska University Hospital. All patients were term and preterm newborn infants. In the first two studies blood was obtained postoperatively after major surgery from patients with wound catheters for determination of Levobupivacaine (LB) concentrations after intermittent (StudyI) or continuous (Study II) infusion with LB: The first study used a sampling protocol of six samples over a 24 hour period and the second study used four samples in 72 hours. Pain was assessed using validated pain scales and morphine consumption was registered. In Study III levels of AAGP was determined in blood sampled from umbilical arteries direct after delivery. Results/Conclusions Studies I and II: The studied infusion regimens with LB administered by wound catheters was associated with plasma levels of LB well below toxicity. We also noted good wound healing, low pain scores and reduced need for opioids compared to our normal clinical experience. Study III: This study suggest a significant correlation between increasing gestational age and increasing levels of AAGP in plasma. AAGP levels in plasma seem to correspond with increasing maturity of the new-born infant. Gender and birth weight did not seem to influence AAGP concentrations in plasma. Infants born vaginally had significantly higher levels of AAGP compared to those born with planned caesarean section. • Local anaesthesia by wound catheter administration in termand preterm new-born infants is a safe method to use. • Gestational age and mode of delivery should be factors when determining dosage of local anaesthetics. 5

[1]  X. Capdevila,et al.  Regional anesthesia and analgesia after surgery in ICU , 2017, Current opinion in critical care.

[2]  S. Eksborg,et al.  Plasma concentrations of levobupivacaine associated with two different intermittent wound infusion regimens following surgical ductus ligation in preterm infants , 2015, Paediatric anaesthesia.

[3]  Brendan J. O'Donnell,et al.  Regional anesthesia for management of acute pain in the intensive care unit , 2015, International journal of critical illness and injury science.

[4]  M. Sesay,et al.  Benefits of intravenous lidocaine on post-operative pain and acute rehabilitation after laparoscopic nephrectomy , 2014, Journal of anaesthesiology, clinical pharmacology.

[5]  T. Wester,et al.  Local delivery of bupivacaine in the wound reduces opioid requirements after intraabdominal surgery in children , 2013, Pediatric Surgery International.

[6]  P. Sacerdote,et al.  Non-analgesic effects of opioids: mechanisms and potential clinical relevance of opioid-induced immunodepression. , 2012, Current pharmaceutical design.

[7]  C. Ecoffey Safety in pediatric regional anesthesia , 2012, Paediatric anaesthesia.

[8]  L. Aarons,et al.  Population pharmacokinetic analysis of ropivacaine and its metabolite 2',6'-pipecoloxylidide from pooled data in neonates, infants, and children. , 2011, British journal of anaesthesia.

[9]  L. Berggren,et al.  A meta‐analysis of the efficacy of wound catheters for post‐operative pain management , 2011, Acta anaesthesiologica Scandinavica.

[10]  A. Yılmazlar,et al.  The effect of local anaesthetic on post-operative pain with wound instillation via a catheter for paediatric orthopaedic extremity surgery , 2011, Journal of children's orthopaedics.

[11]  P. Lönnqvist Regional anaesthesia and analgesia in the neonate. , 2010, Best practice & research. Clinical anaesthesiology.

[12]  R. Burke,et al.  Continuous incisional infusion of local anesthetic in pediatric patients following open heart surgery , 2009, Paediatric anaesthesia.

[13]  H. Kehlet,et al.  Continuous local anesthetic wound infusion to improve postoperative outcome: back to the periphery? , 2007, Anesthesiology.

[14]  A. Moriarty,et al.  The National Pediatric Epidural Audit , 2007, Paediatric anaesthesia.

[15]  Christopher L. Wu,et al.  Effect of Postoperative Analgesia on Major Postoperative Complications: A Systematic Update of the Evidence , 2007, Anesthesia and analgesia.

[16]  Christopher L. Wu,et al.  Efficacy of continuous wound catheters delivering local anesthetic for postoperative analgesia: a quantitative and qualitative systematic review of randomized controlled trials. , 2006, Journal of the American College of Surgeons.

[17]  B. Anderson,et al.  Age and size are the major covariates for prediction of levobupivacaine clearance in children , 2006, Paediatric anaesthesia.

[18]  A. Bösenberg,et al.  Pharmacokinetics and efficacy of ropivacaine for continuous epidural infusion in neonates and infants , 2005, Paediatric anaesthesia.

[19]  C. Greco,et al.  Epidural abscess following epidural analgesia in pediatric patients , 2005, Paediatric anaesthesia.

[20]  K. Anand,et al.  Morphine Administration and Short-term Pulmonary Outcomes Among Ventilated Preterm Infants , 2005, Pediatrics.

[21]  J. Lerman,et al.  Efficacy, Safety, and Pharmacokinetics of Levobupivacaine with and without Fentanyl after Continuous Epidural Infusion in Children: A Multicenter Trial , 2003, Anesthesiology.

[22]  M. Dehan,et al.  Development and initial validation of the EDIN scale, a new tool for assessing prolonged pain in preterm infants , 2001, Archives of disease in childhood. Fetal and neonatal edition.

[23]  Z H Israili,et al.  HUMAN ALPHA-1-GLYCOPROTEIN AND ITS INTERACTIONS WITH DRUGS†,‡ , 2001, Drug metabolism reviews.

[24]  G. Olsson,et al.  Epidural abscess in a one-year-old boy after continuous epidural analgesia. , 1997, Anesthesia and analgesia.

[25]  K.,et al.  Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. , 1997, British journal of anaesthesia.

[26]  G. Olsson,et al.  Plasma Concentrations of Bupivacaine in Neonates After Continuous Epidural Infusion , 1997, Anesthesia and analgesia.

[27]  P. Booker,et al.  Perioperative changes in alpha 1-acid glycoprotein concentrations in infants undergoing major surgery. , 1996, British journal of anaesthesia.

[28]  V. Drossou,et al.  Serum concentrations of 10 acute-phase proteins in healthy term and preterm infants from birth to age 6 months. , 1995, Clinical chemistry.

[29]  L. Herngren,et al.  Effects of pronounced haemodilution on the plasma protein binding of lidocaine , 1995, Perfusion.

[30]  L. Maxwell,et al.  Bupivacaine-induced cardiac toxicity in neonates: successful treatment with intravenous phenytoin. , 1994, Anesthesiology.

[31]  C. Berde Toxicity of local anesthetics in infants and children. , 1993, The Journal of pediatrics.

[32]  C. Lockhart,et al.  Seizures occurring in pediatric patients receiving continuous infusion of bupivacaine. , 1992, Anesthesia and analgesia.

[33]  J. Deshpande,et al.  Bupivacaine toxicity secondary to continuous caudal epidural infusion in children. , 1992, Anesthesia and analgesia.

[34]  J. Lerman,et al.  Effects of age on the serum concentration of α1‐acid glycoprotein and the binding of lidocaine in pediatric patients , 1989, Clinical pharmacology and therapeutics.

[35]  H. Lagercrantz,et al.  The "stress" of being born. , 1986, Scientific American.

[36]  P. Blain,et al.  Determinants of plasma alpha 1-acid glycoprotein (AAG) concentrations in health. , 1985, British journal of clinical pharmacology.

[37]  D. E. Koehntop,et al.  Pharmacokinetics of Fentanyl in Neonates , 1984, Anesthesia and analgesia.

[38]  G. Tucker,et al.  Clinical Pharmacokinetics of Local Anaesthetics , 1979, Clinical pharmacokinetics.

[39]  L. Irestedt,et al.  Concentration of Bupivacaine in Arterial and Venous Plasma After Epidural Anaesthesia in Man and After Intramuscular Administration in Dog , 1975, Acta anaesthesiologica Scandinavica.

[40]  A. Dalmau Llitjos,et al.  [Continuous infusion of local anesthetic at the site of the abdominal surgical wound for postoperative analgesia: a systematic review]. , 2011, Revista espanola de anestesiologia y reanimacion.